The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Aviragen Therapeutics and Vaxart announced the companies have entered into a definitive merger agreement.
read more
Friday, November 03, 2017
Janssen Research & Development
Janssen announced additional analyses from CANVAS clinical trial program showing INVOKANA improved renal outcomes and demonstrated potential renal ...
read more
Friday, November 03, 2017
Symic Bio announced the appointment of Wayne Froland, Ph.D., as Executive Vice President of Technical Operations.
read more
Tuesday, November 07, 2017
Janssen Research & Development
Janssen announced longer-term results from a Phase 2 study investigating TREMFYA, the first selective IL-23 monoclonal antibody to show positive ...
read more
Tuesday, November 07, 2017
OncoResponse has closed the acquisition of Paganini Biopharma, acquiring all of its assets including an anti-epithelial membrane protein 2 (EMP2) ...
read more
Tuesday, November 07, 2017
Novoclem announced its lead inhaled antimicrobial drug candidate, BIOC51, has been designated as a Qualified Infectious Disease Product.
read more
Tuesday, November 07, 2017
Novoclem announced its lead inhaled antimicrobial drug candidate, BIOC51, has been designated as a Qualified Infectious Disease Product.
read more
Wednesday, November 08, 2017
Astellas and Seattle Genetics announced dosing of the first patient in EV-103.
read more
Thursday, November 09, 2017
Neurimmune has entered into a collaboration with Ono Pharmaceutical focused on the development of human antibodies against a novel therapeutic target ...
read more
Friday, November 10, 2017
Amgen and Allergan announced the CHMP of the EMA has adopted a positive opinion for the Marketing Authorization of ABP 215, a biosimilar to Avastin.
read more
Friday, November 10, 2017
Vertex announced that the European Union CHMP issued a positive opinion recommending extension of the Marketing Authorization for ORKAMBI to children ...
read more
Wednesday, November 15, 2017
The MDA announced 13 new research and development grants totaling $3.5 million to accelerate development of treatments for muscular dystrophy, ALS, ...
read more
Thursday, November 16, 2017
Evelo Biosciences announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and ...
read more
Tuesday, November 21, 2017
The Leukemia & Lymphoma Society has committed an additional $46 million to fund the science at medical institutions around the world.
read more
Friday, December 01, 2017
Lannett announced the 505(b)(2) NDA for Cocaine Hydrochloride (HCl) Topical Solution has been accepted for filing with standard review by the FDA.
read more